|
DK3219705T3
(da)
|
2005-12-28 |
2020-04-14 |
Vertex Pharma |
Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
|
|
KR101897881B1
(ko)
|
2008-01-04 |
2018-09-12 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
EP2334315B1
(en)
|
2008-09-03 |
2023-01-18 |
NoNO Inc. |
Agents and methods for treatment of pain
|
|
CA2781888C
(en)
|
2009-12-11 |
2019-06-18 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
ES2593256T3
(es)
|
2010-05-21 |
2016-12-07 |
Infinity Pharmaceuticals, Inc. |
Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
KR101774742B1
(ko)
|
2010-07-16 |
2017-09-11 |
애브비 아일랜드 언리미티드 컴퍼니 |
촉매 반응용 포스핀 리간드
|
|
US8975443B2
(en)
|
2010-07-16 |
2015-03-10 |
Abbvie Inc. |
Phosphine ligands for catalytic reactions
|
|
JP5819959B2
(ja)
|
2010-07-16 |
2015-11-24 |
アッヴィ・バハマズ・リミテッド |
抗ウイルス性化合物を調製するための方法
|
|
US9255074B2
(en)
|
2010-07-16 |
2016-02-09 |
Abbvie Inc. |
Process for preparing antiviral compounds
|
|
WO2012061698A2
(en)
*
|
2010-11-05 |
2012-05-10 |
Senomyx, Inc. |
Compounds useful as modulators of trpm8
|
|
EP2642998B1
(en)
|
2010-11-24 |
2020-09-16 |
The Trustees of Columbia University in the City of New York |
A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
|
|
ES2637113T3
(es)
|
2011-01-10 |
2017-10-10 |
Infinity Pharmaceuticals, Inc. |
Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
|
|
WO2012174488A2
(en)
|
2011-06-15 |
2012-12-20 |
Nono, Inc. |
Agents and methods for treating ischemic and other diseases
|
|
TWI565709B
(zh)
|
2011-07-19 |
2017-01-11 |
英菲尼提製藥股份有限公司 |
雜環化合物及其用途
|
|
KR20130016041A
(ko)
*
|
2011-08-04 |
2013-02-14 |
재단법인 의약바이오컨버젼스연구단 |
신규한 아닐린 유도체 및 이의 용도
|
|
WO2013032591A1
(en)
|
2011-08-29 |
2013-03-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2013119931A1
(en)
*
|
2012-02-10 |
2013-08-15 |
The Board Of Regents Of The University Of Texas System |
Modulators of exchange proteins directly activated by camp (epacs)
|
|
EP2831071B1
(en)
*
|
2012-03-29 |
2018-11-14 |
Merck Sharp & Dohme Corp. |
Imidazolyl methyl piperidine t-type calcium channel antagonists
|
|
US9333202B2
(en)
|
2012-05-01 |
2016-05-10 |
The Trustees Of Columbia University In The City Of New York |
Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
CN103570705B
(zh)
*
|
2012-07-18 |
2017-01-25 |
中国医学科学院医药生物技术研究所 |
取代的n‑((1＇,3＇‑杂唑‑4＇‑基)‑甲基)‑4‑苯甲酰基六氢吡啶类化合物及其用途
|
|
WO2014037900A1
(en)
|
2012-09-07 |
2014-03-13 |
Novartis Ag |
Indole carboxamide derivatives and uses thereof
|
|
BR102012024778A2
(pt)
*
|
2012-09-28 |
2014-08-19 |
Cristalia Prod Quimicos Farm |
Compostos heteroaromáticos; processo para preparar os compostos, composições farmacêuticas, usos e método de tratamento para as dores aguda e crônica
|
|
CN104936963B
(zh)
*
|
2012-11-20 |
2017-11-28 |
普罗齐纳斯有限公司 |
作为蛋白激酶抑制剂的硫醚衍生物
|
|
EP2733146A1
(en)
*
|
2012-11-20 |
2014-05-21 |
KTB Tumorforschungsgesellschaft mbH |
Thioether derivatives as protein kinase inhibitors
|
|
AU2014210259B2
(en)
|
2013-01-25 |
2016-11-03 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
EP3070085B1
(en)
|
2013-02-04 |
2019-01-09 |
Janssen Pharmaceutica NV |
Flap modulators
|
|
TWI644899B
(zh)
|
2013-02-04 |
2018-12-21 |
健生藥品公司 |
Ｆｌａｐ調節劑
|
|
WO2014151959A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
N-alkyl-2-phenoxyethanamines, their preparation and use
|
|
US9944644B2
(en)
|
2013-03-14 |
2018-04-17 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles their preparation and use
|
|
ES2700541T3
(es)
|
2013-03-14 |
2019-02-18 |
Univ Columbia |
Octahidrociclopentapirroles, su preparación y uso
|
|
ES2705247T3
(es)
|
2013-03-14 |
2019-03-22 |
Univ Columbia |
4-fenilpiperidinas, su preparación y uso
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
WO2015039333A1
(en)
*
|
2013-09-22 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
CN105829297B
(zh)
*
|
2013-12-20 |
2019-08-09 |
埃斯蒂文制药股份有限公司 |
具有抗疼痛的多重模式活性的哌啶化合物
|
|
WO2015118167A1
(en)
|
2014-02-10 |
2015-08-13 |
Institut Curie |
Use of mcoln-1 modulators to regulate cell migration
|
|
US20150320755A1
(en)
|
2014-04-16 |
2015-11-12 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
EP4036094A1
(en)
|
2014-04-30 |
2022-08-03 |
The Trustees of Columbia University in the City of New York |
Substituted 4-phenylpiperidines, their preparation and use
|
|
WO2016049774A1
(en)
*
|
2014-10-03 |
2016-04-07 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Urea and bis-urea based compounds and analogues thereof useful in the treatment of androgen receptor mediated diseases or disorders
|
|
JP6746569B2
(ja)
|
2014-10-07 |
2020-08-26 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
嚢胞性線維症膜貫通コンダクタンス制御因子のモジュレーターの共結晶
|
|
EP3848353A1
(en)
|
2014-10-24 |
2021-07-14 |
Takeda Pharmaceutical Company Limited |
Medicaments for the treatment of ophthalmic diseases
|
|
WO2016077793A1
(en)
*
|
2014-11-14 |
2016-05-19 |
Children's Hospital Medical Center |
Sos1 inhibitors for cancer treatment
|
|
SI3321265T1
(sl)
|
2015-03-04 |
2020-07-31 |
Gilead Sciences, Inc. |
Spojine 4,6-diamino-pirido(3,2-d)pirimidina in njihova uporaba kot modulatorji toličnih receptorjev
|
|
US9737512B2
(en)
|
2015-03-11 |
2017-08-22 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for treating chronic pain
|
|
EP3319968A1
(en)
|
2015-07-06 |
2018-05-16 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
|
RS62639B1
(sr)
|
2015-07-06 |
2021-12-31 |
Alkermes Inc |
Hetero-halo inhibitori histonskih deacetilaza
|
|
JP6865743B2
(ja)
|
2015-10-01 |
2021-04-28 |
フィルメニッヒ インコーポレイテッドＦｉｒｍｅｎｉｃｈ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ｔｒｐｍ８の活性調節因子として有用な化合物
|
|
US10450274B2
(en)
*
|
2015-12-07 |
2019-10-22 |
Hinova Pharmaceuticals Inc. |
Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug
|
|
EP3474856B1
(en)
|
2016-06-24 |
2022-09-14 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
US10640499B2
(en)
|
2016-09-02 |
2020-05-05 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
MA46093A
(fr)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Composés modulateurs du recepteur de type toll
|
|
CN106565643A
(zh)
*
|
2016-10-31 |
2017-04-19 |
北京大学 |
D‑3‑磷酸甘油酸脱氢酶别构抑制剂及其应用
|
|
US10722489B2
(en)
*
|
2016-10-31 |
2020-07-28 |
Peking University |
D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof
|
|
RS62959B1
(sr)
|
2017-01-11 |
2022-03-31 |
Alkermes Inc |
Biciklični inhibitori histon-deacetilaze
|
|
CN106822897B
(zh)
*
|
2017-02-17 |
2018-10-19 |
河北盛华尔生物医疗科技有限公司 |
靶向下调trpm7基因表达在提高肺鳞癌化疗敏感性方面的应用
|
|
BR112019020252A2
(pt)
*
|
2017-03-31 |
2020-04-22 |
Perenna Pharmaceuticals Inc |
compostos úteis como inibidores de alcat 1
|
|
TWI848911B
(zh)
|
2017-06-15 |
2024-07-21 |
美國哥倫比亞大學紐約市信託會 |
以三唑并吡啶治療rbp4相關疾病之方法
|
|
TWI841532B
(zh)
|
2017-06-15 |
2024-05-11 |
開曼群島商貝利特生物股份有限公司 |
以稠合雙環吡唑治療代謝疾病之方法
|
|
WO2018232160A1
(en)
*
|
2017-06-15 |
2018-12-20 |
Belite Bio, Inc |
Methods of treating metabolic diseases with phenoxyethylamides
|
|
MD3664802T2
(ro)
|
2017-08-07 |
2022-07-31 |
Alkermes Inc |
Inhibitori biciclici ai deacetilazei histonei
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TW202115056A
(zh)
|
2019-06-28 |
2021-04-16 |
美商基利科學股份有限公司 |
類鐸受體調節劑化合物的製備方法
|
|
WO2021007172A1
(en)
|
2019-07-08 |
2021-01-14 |
Belite Bio, Llc |
Formulations of rbp4 inhibitors and methods of use
|
|
US11091447B2
(en)
|
2020-01-03 |
2021-08-17 |
Berg Llc |
UBE2K modulators and methods for their use
|
|
US11691971B2
(en)
|
2020-06-19 |
2023-07-04 |
Incyte Corporation |
Naphthyridinone compounds as JAK2 V617F inhibitors
|
|
US11753413B2
(en)
|
2020-06-19 |
2023-09-12 |
Incyte Corporation |
Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
|
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
|
JP2023533724A
(ja)
|
2020-07-02 |
2023-08-04 |
インサイト・コーポレイション |
Ｊａｋ２ ｖ６１７ｆ阻害剤としての三環式尿素化合物
|
|
WO2022046989A1
(en)
|
2020-08-27 |
2022-03-03 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|
|
WO2022119823A1
(en)
*
|
2020-12-04 |
2022-06-09 |
The Johns Hopkins University |
Compounds and their use for treating neuropathic pain
|
|
WO2022140231A1
(en)
|
2020-12-21 |
2022-06-30 |
Incyte Corporation |
Deazaguaine compounds as jak2 v617f inhibitors
|
|
WO2022148781A1
(en)
|
2021-01-05 |
2022-07-14 |
Institut Curie |
Combination of mcoln activators and immune checkpoint inhibitors
|
|
US11958861B2
(en)
|
2021-02-25 |
2024-04-16 |
Incyte Corporation |
Spirocyclic lactams as JAK2 V617F inhibitors
|
|
CN114685371A
(zh)
*
|
2022-03-08 |
2022-07-01 |
四川大学 |
吡唑甲酰胺衍生物及其制备方法和用途
|
|
WO2023178285A1
(en)
|
2022-03-17 |
2023-09-21 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|
|
JP7360634B2
(ja)
|
2022-03-23 |
2023-10-13 |
いすゞ自動車株式会社 |
車両制御システム及び荷役制御システム
|
|
WO2024059524A1
(en)
*
|
2022-09-12 |
2024-03-21 |
Hotspot Therapeutics, Inc. |
Pyrazolylcarboxamide compounds and their use in therapy
|
